Blijlevens, N <br/><br/>
In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burden.  [electronic resource] 

 -  Bone marrow transplantation  Jul 2013 
 - 966-71 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/bmt.2012.257  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Autografts<br/>Female<br/>Fibroblast Growth Factor 7--administration & dosage<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Multiple Myeloma--epidemiology<br/>Myeloablative Agonists<br/>Stem Cell Transplantation<br/>Stomatitis--epidemiology<br/>Transplantation Conditioning